The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies

Autor: Cirkel, G.A., Weeber, F., Bins, S., Gadellaa-van Hooijdonk, C.G.M., van Werkhoven, E., Willems, S.M., van Stralen, M., Veldhuis, W.B., Ubink, I., Steeghs, N., de Jonge, M.J., Langenberg, M.H.G., Schellens, J.H.M., Sleijfer, S., Lolkema, M.P., Voest, E.E. *
Zdroj: In Annals of Oncology August 2016 27(8):1638-1643
Databáze: ScienceDirect